Live Breaking News & Updates on Channel Biosciences
Stay updated with breaking news from Channel biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Acquired exclusive license for oral, brain-penetrant, dual TYK2/JAK1 inhibitor for immune-mediated brain disorders in March 2023 covering global (ex-China). ....
You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and related notes appearing elsewhere in this Annual. | March 23, 2023 ....
Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. today announced that the companies have entered into a definitive agreement under which Pfizer. ....